Chemotherapy-free phase 1/2 trial of HRS-4642 plus adebrelimab in previously treated metastatic KRAS G12D-mutant pancreatic cancer. // Cancer Cell. – URL: https://www.sciencedirect.com/science/article/pii/S1535610826003892?dgcid=rss_sd_all
Chemotherapy-free phase 1/2 trial of HRS-4642 plus adebrelimab in previously treated metastatic KRAS G12D-mutant pancreatic cancer. Cancer Cell. https://www.sciencedirect.com/science/article/pii/S1535610826003892?dgcid=rss_sd_all
“Chemotherapy-free phase 1/2 trial of HRS-4642 plus adebrelimab in previously treated metastatic KRAS G12D-mutant pancreatic cancer.” Cancer Cell.
@article{article2029,
title = {Chemotherapy-free phase 1/2 trial of HRS-4642 plus adebrelimab in previously treated metastatic KRAS G12D-mutant pancreatic cancer},
journal = {Cancer Cell},
url = {https://www.sciencedirect.com/science/article/pii/S1535610826003892?dgcid=rss_sd_all}
}